PUBLISHER: GlobalData | PRODUCT CODE: 1746811
PUBLISHER: GlobalData | PRODUCT CODE: 1746811
Contrast Media Injectors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Diagnostic Imaging therapeutic area.
Contrast Media Injectors are devices used to inject contrast media agents into the bloodstream of patients, to enable visualization of various pathologies through X-ray, computed tomography, magnetic resonance imaging, or other medical imaging devices.
Contrast Media Injectors come in three types: Computed Tomography (CT) Injectors, MRI Injectors, and Angiography Injectors. They can be classified based on their construction as either power or pressure injectors. In imaging and interventional radiology, both pressure and power injectors assist in the opacification and delineation of normal anatomy, including arterial and venous structures, as well as abnormal lesions. The contrast media injectors market is fueled by the increasing demand for diagnostic imaging systems like MRI and CT scanners. This demand has been driven by aging global populations and the growing incidence of chronic diseases.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Contrast Media Injectors and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Bayer AG, Nemoto Kyorindo Co Ltd, Guerbet SA, Bracco Imaging SpA, Sino Medical-Device Technology Co., Ltd., ulrich GmbH & Co KG and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -